Trial Profile
Phase 2 study of alternate-day administrations of S-1 in elderly patients with advanced/recurrent gastric cancer (KDOG 1301)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Aug 2020
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Carcinoma; Gastric cancer
- Focus Therapeutic Use
- 05 Aug 2020 Status changed from recruiting to completed.
- 27 Feb 2014 New trial record